Category Archives: News

You are here:

Home
Category "News"

PRIME Archived Webinars

PRIME Archived Webinars Now Online! Managing Toxicities of Novel Therapies and Coordinating Care for CLL/SLL and FL Patients PRIME in partnership with...

November 15, 2018NewsBy Brad Hedrick

Duvelisib approved for Relapsed and Refractory CLL after failing 2 lines of therapy

For chronic lymphocytic leukemia patients, it is always good to have more options. The FDA’s approval of duvelisib, a very effective...

September 27, 2018Business, Finances, Insurance & RegulatoryBy Patty Koffman

Get Ready for Flu Season

When it comes to contagious diseases like the flu, CLL patients are among the most vulnerable to infection and serious...

September 21, 2018ClinicalBy Brad Hedrick

Minimal Residual Disease Negativity Data, a Measure of Undetectable Disease, Added to Venetoclax tablet Label

Minimal residual disease (MRD)-negativity is a big deal and is now being recognized right on the label of venetoclax, a...

September 18, 2018Business, Finances, Insurance & RegulatoryBy Brad Hedrick

Blood Cancer Awareness Month

Blood Cancer Awareness Month takes place every September. The CLL Society joins 100s of other nonprofits and charities in promoting...

September 10, 2018ClinicalBy Brad Hedrick

FDA Approval of Ibrutinib with Rituximab for Waldenström’s Macroglobulinemia

Ibrutinib plus Rituximab is now approved by the FDA in Waldenström's Macroglobulinemia (WM), a rare form of non-Hodgkin's lymphoma and...

August 28, 2018Business, Finances, Insurance & RegulatoryBy Brad Hedrick

The Daily Breeze has captured Stan Kurtz' amazing swim in this article that you can read here! https://www.dailybreeze.com/2018/08/05/tarzana-man-swims-22-miles-from-catalina-island-to-rancho-palos-verdes-to-raise-funds-for-leukemia-organization/ ...

August 6, 2018NewsBy Brad Hedrick

FDA Approval of Venetoclax in Combination with Rituximab (V+R) for Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Patients Who Have Received One Prior Therapy

This is great news for CLL patients a few good reasons. First it is the first non-chemo combination approved for...

June 9, 2018Business, Finances, Insurance & RegulatoryBy Todd Dennison

FDA Approves Kymriah (tisagenlecleucel) for DLBCL

May 7, 2018 - The U.S. Food and Drug Administration (FDA) granted tisagenlecleucel (Kymriah®), formerly known as CTL019, its second...

May 8, 2018Business, Finances, Insurance & RegulatoryBy Todd Dennison

Day 29: The Killing Frenzy is Done- Time to Celebrate Being CLL Free

Killing Frenzy from our CAR-T comic book I received my CAR-T cells on March 22, a Thursday, so Thursdays, every 7...

April 21, 2018 38 CommentsCAR-T Blog, NewsBy Brian Koffman